Discover the latest insights from the TOReTO study on COPD management: Dual bronchodilator therapy has been shown to reduce exacerbations, with varying efficacy between current and former smokers.

The diagnosis of COPD can be frustrating for ... that group A patients receive short-acting bronchodilators, whereas group B must be given long-acting muscarinic antagonist (LAMA) or a LABA ...

A new study suggests COPD patients experience improved lung function and breathlessness after direct switch from long-acting bronchodilators or steroid containing combination therapies to ...

A total of 2,802 patients with COPD were randomised 1:1 to receive ... and could include single or dual long-acting bronchodilator therapy, inhaled corticosteroid either alone or in combination ...

Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive ...

The right treatment plan can help you control your COPD symptoms and avoid exacerbations (flareups). These include shortness ...

Chronic obstructive pulmonary disease (COPD) is a disease of the respiratory tract that is characterized narrowing of the small airways and destruction of lung tissue. This leads to poor airflow ...

The Bronchodilator Drugs market in North Macedonia is expected to witness a substantial increase in revenue, reaching US$2.28m in 2024. Furthermore, it is projected that the market will exhibit a ...

Ohtuvayre™ (ensifentrine) launch recorded Q3 net sales of $5.6 million and October net sales exceeded Q3Through October more than 2,200 unique ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

and chest tightness caused by lung diseases such as asthma and chronic obstructive pulmonary disease (COPD); a group of diseases that affect the lungs and airways. It relaxes the smooth muscles in ...